摘要：Correction to:
Scientific Reports 10.1038/s41598-017-06927-0, published online 25 July 2017
This Article contains an error in Figure 6, where the Control and Platelet images for Control siRNA and Integrin beta 3 siRNA groups were mistakenly taken from the same original image file in panel (d).
The correct Figure
6 and accompanying legend appear below.
Figure 6
The integrin β3/Akt signaling contributed to platelet-induced EOMA cell proliferation. (
a) EOMA cells were transfected with control or integrin β3 siRNA for 4 days, and then treated with platelets for another 72 hours. The cell viability was examined using the CCK8 assay. (
b) The EOMA cells were incubated with indicated concentrations of Akt inhibitor GSK690693 for 72 hours. GSK690693 treatments with 1 and 2 μM did not significantly affect EOMA cell survival. (
c) EOMA cells were pre-treated with Akt inhibitor GSK690693 for 3 hours, and then incubated with platelets for another 72 hours. The cell viability was examined using the CCK8 assay. (
d) EOMA cells were either transfected with control or integrin β3 siRNA for 4 days, or pre-treated with GSK690693 for 3 hours, and then incubated with platelets for another 48 hours. The cell proliferation was assessed via the EdU assay. Scale bar, 60 μm. n = 3–5, one-way or two-way ANOVA. *P < 0.05; **P < 0.01; ***P < 0.001; ns, not significant.
Additionally, an incorrect email address for author Xiao-Ming Chen is quoted. Correspondence and requests for materials should be addressed to cxm@wmu.edu.cn.
